Material Type

• Blood (whole) (3)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Plasma (single spun) (3)
• Saliva (3)
• Serum (3)
• Swab medium (3)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Affected (1)
• Not applicable (4)

Storage Temperature

• -85°C to -60°C (5)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (4)
• Followup records (3)
• Freezer temperature logs (1)
• Genomic datasets (1)
• Microbiological results (3)
• Physiological/biochemical measurements (3)
• Pre-analytical data (4)
• Quality indicators (2)
• Survey data (2)
• Treatment records (1)

Timeframe

• Immediate (1)
• 0 - 3 months (3)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 11 - 100 (1)
• 101 - 500 (3)
• 1001 - 3000 (1)
• 3001 - 5000 (1)

Sex

• Both sexes (4)
• Undifferentiated (1)

Age Range

• Adolescent (12 - 18 years) (1)
• Young adult (18 - 40 years) (4)
• Adult (> 40 years) (1)
• Data not recorded (1)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Data analytics (3)
• Digital imaging (1)
• Nucleic acid extraction (1)

Collection Type

• Disease specific (5)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (5)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (4)
• No restrictions (0)
• No Project specific restriction (4)
• No Scope of use restriction (2)

Collection Status

• Completed (2)
• In progress (3)

Access Condition

• Open to applicants (4)
• Open only through collaboration (1)

Country

• France (1)
• Peru (1)
• South Africa (1)
• Switzerland (1)
• United States (1)

County